Short vs Long Blood Thinner Use After TAVI
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares a short course versus a longer course of antiplatelet medicine (blood thinners) after a TAVI procedure for aortic stenosis. It aims to see which approach is safer and more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a successful TAVI procedure for aortic stenosis through a leg artery.
- You are 18 years old or older.
- You do not need long-term blood thinners for other heart or blood vessel conditions.
- You are not on any anticoagulant (like warfarin) for conditions such as atrial fibrillation.
- You speak French and have French social security.
- Women: You must be past menopause (no period for 12 months) or surgically sterilized.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether an oral blood thinner (apixaban) works for people who recently received a bioprosthetic aortic valve. It aims to prevent dangerous blood clots while checking safety, especially bleeding risk.
This trial tests how long patients should take two blood-thinning medications (aspirin and clopidogrel) after treatment to restore blood flow to a severely damaged leg. The goal is to find the right balance between preventing clots and avoiding dangerous bleeding.
This trial tests if a very short course of dual antiplatelet therapy (two blood thinners) after getting a stent is safe and effective for patients aged 65 and older. The goal is to reduce bleeding risks while still preventing heart attacks.
This trial is for people who have had a TAVI procedure to replace a narrowed heart valve, and it tests whether it is safe to skip blood thinners afterward. The goal is to find the best way to protect your health without unnecessary medication.
This trial tests whether a personalized plan for blood thinners after TAVI can reduce the risk of stroke or bleeding better than the current standard of one daily blood thinner. If you've had a successful TAVI and don't need specific other blood thinners, you might be able to join.
This trial compares aspirin and clopidogrel (two blood-thinning medicines) after TAVR to see which is safer or more effective for preventing clots. You may be able to join if you recently had a TAVR for severe aortic valve narrowing and can follow the study plan.
Hear when a new Transcatheter Aortic Valve Replacement trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.